QL
NMRA icon

Quarry LP’s Neumora Therapeutics NMRA Stock Holding History

Quarry LP’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,000
Closed -$53K – 1898
2024
Q4 		$53K Hold
5,000
– – 0.01% 724
2024
Q3 		$66K Sell
5,000
-5,000
-50% -$58.3K 0.02% 593
2024
Q2 		$98.3K Buy
+10,000
New +$103K 0.03% 352
2024
Q1 		– Sell
-50
Closed -$853 – 1829
2023
Q4 		$853 Buy
+50
New +$614 ﹤0.01% 1358

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

Quarry LP's NMRA Position: Q1 2025 in Review

Quarry LP sold out of Neumora Therapeutics (NMRA) in Q1 2025, closing a stake of 5,000 shares — an estimated $53K sold.

Quarry LP first reported a position in NMRA in Q4 2023 and held it in 4 quarters. The position peaked at $98.3K in Q2 2024. 115 funds tracked by Wall St. Rank hold NMRA as of Q1 2025.

  • Quarry LP reported no remaining Neumora Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Quarry LP sold 5,000 Neumora Therapeutics shares in Q1 2025, an estimated $53K.
  • Quarry LP first reported a position in Neumora Therapeutics in Q4 2023 and held it in 4 quarters.
  • Quarry LP's Neumora Therapeutics position peaked at $98.3K in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2025.

Based on Quarry LP's 13F filing for Q1 2025, filed 15 May 2025.